Innovation Capital
VC Fund
Paris, France
Innovation Capital is a French international venture capital firm focused on investments in healthcare services.
- Total investments:
- 26
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Innovation Capital invests in
SoftwareManufacturingHealth CareBiotechnologyMobile
Stages Innovation Capital invests in
Series BSeries DSeries ASeries CFunding Round
Countries Innovation Capital invests in
FranceUnited StatesUnited KingdomGermany
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Investment Focus
Industry
- Software 6 (23%)
- Manufacturing 5 (19%)
- Health Care 4 (15%)
- Biotechnology 4 (15%)
- Mobile 3 (12%)
Stage
- Series B 8 (31%)
- Series D 5 (19%)
- Series A 2 (8%)
- Series C 2 (8%)
- Funding Round 2 (8%)
Country
- France 14 (54%)
- United States 3 (12%)
- United Kingdom 2 (8%)
- Germany 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chantal Parpex
President & Managing Partner
|
President & Managing Partner | Total investments: 0 | Find email | |
Florian Reinaud
Partner
|
Partner | Total investments: 0 | Find email | |
Mathilde Pouliquen
Middle Office
|
Middle Office | Total investments: 0 | Find email | |
Michael Quinn
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
Michel Desbard
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Fabrico SaaS
|
Fabrico is a cloud-based CMMS that manages all maintenance activities in a manufacturing facility by combining lean end-to-end maintenance methodologies.Everything required to digitalize all maintenance procedures in your plant is included in the solution. Fabrico offers preventive and reactive maintenance solutions, as well as an efficientticketing system that allows for entire communication and compliance processes in a single plant. | $720.5K / Seed / Oct 24, 2023 | |
GeoSpock
|
GeoSpock enables data fusion for the connected world with GeoSpock DB – the space-time analytics database. GeoSpock DB is a unique, cloud-native database optimised for querying for real-world use cases, able to fuse multiple sources of Internet of Things (IoT) data together to unlock its full value, whilst simultaneously reducing complexity andcost. GeoSpock DB enables efficient storage, data fusion, and rapid programmatic access to data, and allows you to run ANSI SQL queries and connect to standard analytics tools via flexible JDBC/ODBC connectors. Users are able to perform deep analysis and share insights using familiar toolsets, with plug and play support for common BI tools (such as Tableau™, Amazon QuickSight™, and Microsoft Power BI™), and Data Science and Machine Learning environments (including Python Notebooks and Apache Spark). The database can also be integrated with proprietary applications, web services, and internal tools – with compatibility for open-source and customisable visualisation libraries such as Kepler and Cesium.js. | $12.7M / Series B / Jan 08, 2019 | |
Wandercraft
|
Wandercraft develops autonomous walking exoskeletons and robotic systems designed to restore upright mobility to individuals with walking impairments. The company offers devices such as Atalante X, a hands‑free, self‑balancing exoskeleton used in rehabilitation centers, and a Personal Exoskeleton prototype that leverages AI‑driven balance tosupport walking in daily life. Their systems incorporate real‑time adaptive gait algorithms and powered joints to facilitate multidirectional movement and support early intensive rehabilitation. Wandercraft collaborates with healthcare institutions and has initiated clinical trials to evaluate safety and effectiveness in managing spinal cord injuries and stroke rehabilitation. | $25M / Series B / Oct 11, 2017 | |
Ekinops
|
Ekinops is a provider of next-generation optical transport solutions for service providers and private networks. Its carrier-grade solutions leverage expertise in 10G transmission, aggregation and Forward Error Correction (FEC) to allow operators to cost-effectively increase data transport capacity over dark fiber, CWDM, DWDM, SONET/SDH, IPand SAN networks. | $14.2M / Post-IPO Equity / Jun 29, 2017 | |
Expway
|
EXPWAY is the world leader in Mobile Broadcast and Multicast Solutions. The company's fastest growing market is on LTE BROADCAST i.e. eMBMS. Expway provides eMBMS BM-SC SERVERs that allow the operator to create multicast streams, both live TV and push files in any format, and broadcast them at the LTE network. Its eMBMS MIDDLEWARE controls theLTE modem, and receives and decodes the broadcast streams on the device. | $3.3M / Mar 31, 2016 | |
Voluntis
|
Voluntis is a healthcare software company specialized in Patient Relationship Management (PRM). Their mission is to enable healthcare organizations to deliver outstanding patient monitoring and support services through the use of advanced information and communication technologies.Voluntis was founded in 2001 by three entrepreneurs who believedthat innovative medical solutions built with advanced information technologies would improve medical real-life outcomes and thus increase healthcare system efficiency. This would transform patient lives, enhance medical practices and quality of care.Every day, Voluntis teams seek to invent secure, collaborative and patient-centric digital health solutions with a unique combination of web and mobile development excellence, medical and regulatory expertise and certified quality-oriented processes. With more than 600,000 patients managed and more than 50 programs deployed, their track record speaks for itself. | $29M / Series D / Apr 28, 2014 | |
Cytheris
|
Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such aschemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT). | $15M / Series D / Jun 07, 2010 | |
Santen Pharmaceutical
|
Santen specializes in the research, development, marketing, and sales of innovative eye care products and services that enable optimal sight. They help physicians address the complex clinical challenges in vision care with novel solutions for glaucoma, retinal diseases, and other eye conditions. | $16.5M / Post-IPO Equity / Sep 26, 2009 | |
Radio Systemes Ingenierie
|
Radio Systemes Ingenierie S.A. provides wireless communication systems. It offers Visioguard, a wireless alarm system that provide remote video monitoring, local monitoring with a TV or a monitor, integrated Internet-server, and emails with attached video-files. The company was founded in 2000 and is based in Strasbourg, France. | $8.7M / Series D / May 18, 2009 | |
Novaled
|
Novaled AG is a world-class technology provider in organic light-emitting diode (OLED) technologies. With expertise in synthetic and analytical chemistry, it offers complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials.Novaled has developed long-term partnerships with major OLEDplayers worldwide. Its strong IP position in OLED technology is based on more than 500 patents granted or pending. In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia. | $12.3M / Series C / Jan 17, 2009 | |
| See all 26 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Climate Investors
40,325 investors
Manufacturing Investors
24,696 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Mobile Investors
12,672 investors
SaaS VC Funds
61,208 investors
FAQ
What does Innovation Capital invest in?
Innovation Capital invests primarily in Software, Manufacturing and Health Care startups, most often at Series B and Series D stage. Most of the 26 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Innovation Capital?
Public channels for Innovation Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Innovation Capital?
The team at Innovation Capital includes Chantal Parpex (President & Managing Partner), Florian Reinaud (Partner) and Mathilde Pouliquen (Middle Office), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
